Skip to main content
Home How It Works Technology Use Cases Ethics & Safety Team
Contact
Home How It Works Technology Use Cases Ethics & Safety Team Contact

Accessibility Statement for MyoLogIQ

MyoLogIQ is fundamentally committed to ensuring digital accessibility, equity, and inclusion for all individuals, including those with disabilities. We are continually optimizing the user experience across our digital properties, applying advanced design principles to conform directly with the Web Content Accessibility Guidelines (WCAG) version 2.2, Level AA conformance standards.

Measures Taken to Optimize Accessibility

To ensure an operable, perceivable, and robust experience across our digital interfaces, the MyoLogIQ platform natively implements the following engineering controls:

Semantic HTML Architecture: Our codebase utilizes clean structural elements (headers, main blocks, footers, and descriptive labels) to guarantee flawless interpretation by modern assistive reading technologies.

Keyboard Navigation & Focus Indicators: Every user interaction pathway, drop-down selection menu, and contact funnel is completely operable using standard keyboard navigation without requiring mouse tracking.

Color Contrast Optimization: Visual layouts are strictly calibrated to exceed standard contrast metrics, ensuring text-to-background visual ratios remain fully legible for low-vision profiles.

Responsive Layout Stability: The interface scales dynamically to varied magnification profiles and alternative viewport dimensions without causing component overlap or text spilling.

Feedback and Contact Information

Digital accessibility is an ongoing optimization pipeline. If you encounter any technical limitations, structural blockers, or display anomalies while navigating the platform, please notify our compliance team immediately:

Email: Support@MyoLogIQ.com

Response Timeline: We aim to review all structural accessibility reports and provide an actionable remediation response within five business days.

This statement was last reviewed and verified for compliance on May 18, 2026.

MyoLogIQ

Next-generation visual physiological intelligence for anti-doping workflows. We provide non-invasive morphological tracking over time to help sports organizations eliminate testing blind spots

Company

  • Home
  • Team
  • Contact

Product

  • How It Works
  • Technology
  • Use Cases

Legal

  • Ethics & Safety
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement

© 2026 MyoLogIQ LTD. All rights reserved.